Recombinant Vaccines Market Size, Share, Growth Report 2030
Recombinant Vaccines Market By Product (Attenuated, Vector, and Subunit), By Application (Veterinary and Human), By Disease (Hepatitis B, Cancer, Influenza, and Others), and By Distribution Channel (Hospitals, Clinics, Veterinary Clinics, Retail Pharmacies, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025
Global recombinant vaccines market expected to generate around USD 1,685 million by 2025, at a CAGR of around 6.5% between 2019 and 2025. Recombinant DNA molecules are prepared by genetic recombination methods to link genetic material from various sources.
The report covers a forecast and an analysis of the recombinant vaccines market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the recombinant vaccines market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the recombinant vaccines market on a global and regional level.
In order to give the users a comprehensive view of the recombinant vaccines market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the recombinant vaccines market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the recombinant vaccines market on a global and regional basis.
The study provides a decisive view of the recombinant vaccines market by segmenting the market based on type, application, disease, distribution channel, and region. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Some key players of the global recombinant vaccines market are Pfizer, Merck, Sanofi Pasteur, Bayer, GlaxoSmithKline, Serum Institute of India, Abiomed, Johnson & Johnson, Emergent Bio Solutions, and Mitsubishi Tanabe Pharma.
This report segments the global recombinant vaccines market as follows:
Global Recombinant Vaccines Market: By Type
- Attenuated
- Vector
- Subunit
Global Recombinant Vaccines Market: By Application
- Veterinary
- Human
Global Recombinant Vaccines Market: By Disease
- Hepatitis B
- Cancer
- Influenza
- Others
Global Recombinant Vaccines Market: By Distribution Channel
- Hospitals
- Clinics
- Veterinary Clinics
- Retail Pharmacies
- Others
Global Recombinant Vaccines Market: By Region
- North America
- The U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- Middle East and Africa
Table Of Content
Methodology
Free Analysis
Choose License Type
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed